El vino a dosis moderadas: Salud o enfermedad

Medicina Clinica

Volumn 112, Issue 1, 1999, Pages 29-35

  Bujanda, Luis ^a,c   Gutiérrez Stampa, Ma Ángeles ^b   Marimón, José Maria ^c  

^a Hospital de San Eloy   (Spain)

^b Hospital Nuestra Senora de Aranzazu   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; BREAST TUMOR; CARDIOVASCULAR DISEASE; DRINKING BEHAVIOR; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LIFE EXPECTANCY; MALE; NEOPLASM; NEUROLOGIC DISEASE; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; URINARY TRACT DISEASE; WINE;

ALCOHOL DRINKING; ALCOHOLISM; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; FEMALE; GASTROINTESTINAL DISEASES; HEMATOLOGIC DISEASES; HUMANS; LIFE EXPECTANCY; MALE; NEOPLASMS; NERVOUS SYSTEM DISEASES; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; UROLOGIC DISEASES; WINE;

EID: 0033573617     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (152)

1. Willett WC. Diet and health: what should we eat? Science 1994; 264: 532-537.
2. San Molina L. ¿Tiene el alcohol algün efecto beneficioso? Med Clin (Barc) 1996; 107: 655-656.
3. World Health Organization. ICD-10 Classification of mental and behavioural disorders. WHO: Churchill-Livingstone, 1994.
4. Allisent R, Cordoba R. Definición del consumo excesivo de alcohol y sus implicaciones. Aten Primaria 1993; 11: 381-382.
5. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1.103-1.104.
6. Muller CJ, Fugelsang KC. Take two glasses of wine and see me in the morning. Lancet 1994; 343: 1.428-1.429.
7. Golberg DM. Does wine work? Clin Chem 1995; 41: 14-16.
8. Singleton VL. Grape and wine phenolics: background and prospects. En: Singleton VL, editor. Proceedings of Symposium: Grape and wine centennial, 1980. Davis: University of California Press. 1982; 215-227.
9. Goldberg DM. More on antioxidant activity of resveratrol in red wine. Clin Chem 1996; 42: 113-114.
10. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of polygonum cuspidatum Sieb et Zucc, on lipid metabolism. Chem Pharm Bull 1982; 30: 1.766-1.779.
11. Goldberg DM, Soleas GJ, Hahn SE, Diamandis EP, Karumanchin A. Identification and assay of trihydroxy salbenes in wine and their biological properties. En: Watkins TR, editor. Chemistry and biology of wine phenolics. Washington, DC: American Chemical Society, 1996; 130-148.
12. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994; 344: 193-194.
13. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on antioxidant capacity of serum. Clin Chem 1995; 41: 32-35.
14. Klurfeld DM, Kritchevsky D. Differential effects of alcholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol 1981; 34: 62-71.
15. Serra-Majem L, Ribas L, Tresserras R, Ngo J, Salleras L. How could changes in diet explain changes in coronary heart disease mortality in Spain? The Spanish paradox. Am J Clin Nutr 1995; 61 (Supl): 1.351-1.359.
16. Banegas JR, Villar F, Martin Moreno JM, Rodriguez Artalejo F, González J. Relevancia de la mortalidad por enfermedades del aparato circulatorio en España. Rev Clin Esp 1992; 190: 321-327.
17. Rimm EB, Giovannucci EL, Willett WC, Golditz GA, Ascherio A, Rosner B et al. Prospective study of alcohol consumption and the risk of coronary disease in men. Lancet 1991; 338: 464-468.
18. Rimm EB, Ellison RC. Alcohol in the Mediterranean diet. Am J Clin Nutr 1995; 61 (Supl): 1.378-1.382.
19. Rimm EB. Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. Am J Epidemiol 1996; 143: 1.094-1.098.
20. Rosenberg L, Metzger LS, Palmer JR. Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. Epidemiol Rev 1993; 15: 133-144.
21. Renaud S, De Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992; 339: 1.523-1.526.
22. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: do red wine drinkers fare best? Am J Cardiol 1993; 71: 467-469.
23. Farchi G, Fidanza F, Marlotti S, Menotti A. Alcohol and mortality in the Italian rura cohorts of the Seven Countries Study. Int J Epidemiol 1992; 21: 74-81.
24. Stampfer MJ, Colditz GA, Willett WC, Spelzer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319: 267-273.
25. Jepson RG, Fowkes FG, Donnan PT, Housley E. Alcohol intake as a risk factor for periphera, arterial disease in the general population in the Edinburgh Artery Study. Eur J Epidemiol 1995; 11: 9-14.
26. SI, Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; 1: 1.017-1.020.
27. Hegsted DM, Ausman LM. Diet, alcohol and coronary heart disease in mer. J Nutr 1988; 118: 1.184-1.189.
28. Fredman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986; 124: 481-489.
29. Gronback M, Deis A, Sorensen TiA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer or spirits. Br Med J 1995; 310: 1.165-1.169.
30. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawai. N Engl J Med 1977; 297: 405-409.
31. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van Deuburg M et al. Moderate alcohol intake, increase levels of high-density lipoprotein and its subfreactions and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1.829-1.834.
32. Salonen JT, Puska P, Nissinen A. Intake of spirits and beer and risk of myocardial infarction and death: a longitudinal study in eastern Finland. J Chron Dis 1983; 36: 533-543.
33. Kitner SJ, García PM, Sostas RJ, Cruz VM, Abbott RD, Havilk RJ. Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol 1983; 117: 538-550.
34. Marqués-Vidal P, Ducimetiere P, Evans A, Cambou JP, Arveller D. Alcohol consumption and myocardial infarction: a case-control study in France and Northern Ireland. Am J Epidemiol 1996; 143: 1.089-1.093.
35. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? Br Med J 1996; 312: 731-736.
36. Dulcimetiere P, Guize L, Marcinlak A, Milon H, Richard J, Rufat P. Arteriographically document coronary artery disease and alcohol consumption in French men. The CORALI Study. Eur Heart J 1993; 14: 727-733.
37. Taskinen MR, Nikkila EA, Valimaki M, Sane T, Kuusi T, Kesaniemi A et al. Alcohol-induced changes in serum lipoprotems and their metabolism. Am Heart J 1987; 113: 458-464.
38. Lavy A, Fuhrman B, Markel A, Dankner G, Ben-Amotz A, Presser D et al. Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein. Ann Nutr Metab 1994; 38: 287-294.
39. Van Tol A, Groener JE, Scheek LM, Van Gent T, Veenstra J, Van de Pol H et al. Induction of net mass lipid transfer reactions in plasma by wine consumption wilh dinner. Eur J Clin Invest 1995; 25: 390-395.
40. Álvarez-Sola Walther LA. Milan Nuñez-Cortés J, De Oya Otero M. La dieta mediterránea en España. ¿Leyenda o realidad? (I). El estudio de siele paises. Algunos elementos de la dieta mediterránea: el aceite de oliva y el vino tinto. Rev Clin Esp 1996; 196: 62-70.
41. Savolainen MJ, Kesaniemi YA. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol 1995; 6: 243-250.
42. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-381.
43. Steinberg D, Parrthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low density lipoproteins that increases its atherogenicity. N Engl J Med 1989; 320: 915-924.
44. Stampfer MJ, Hennekens CH, Manson JE, Colcitz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary artery disease in women. N Engl J Med 1993; 328: 1.444-1.499.
45. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz E, Willett WC. Vitamin E consumption and the risk of coronary artery disease in men. N Engl J Med 1993; 328: 1.450-1.456.
46. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibit on of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457.
47. Sharpe PV, McGrath LT, McClean B, Young IS, Archbold GP. Effect of red wine consumption on lipoprotein and other risk factors for atherosclerosis. QJM 1995; 88: 101-108.
48. Serafint M, Ghiselli A, Ferro-Luzzi A. Red wine, tea and antioxidants. Lancet 1994; 344: 626.
49. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low-density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six years follow-up in the Copenhagen male study. Br Med J 1996; 312: 736-741.
50. Caldú P, Hurtado I, Floi C, Gonzalo A, Mínguez S. White wine reduces the susceptibility of low-density lipoprotein to oxidation. Am J Clin Nutr 1996; 63: 403-404.
51. De Rijke YB, Demacker PNM, Assen NA, Sloots LM, Katan MB, Stalenhoef AFH. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am J Clin Nutr 1996; 63: 329-334.
52. Fitzgerald DF, Hirschfield SL, Cofley RG. Endotholium-dependent vaso-relaxing activity of wine and other grape products. Am J Physiol 1993; 265: 774-778.
53. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma cocentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-933.
54. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits m vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995; 91: 1.182-1.188.
55. Janssen PLTMK, Katan MB, Hollman PCH, Venema DP. No aspirin in red wine. Lancet 1994; 344: 762.
56. Fornells JM. Balaguer I. Control de la hipertensión en el medio rural: 18 meses de seguimiento (programa CRONICAT). Med Clin (Barc) 1990; 94: 570-575.
57. Armario Garcia P, Hernandez del Rey R, Gasulla Roso JM, Alonso Fresneda A, Tresserras R, Pardell Alenta H. Prevalencia de hipertension arterial en L'Hospitalet de Llobregat. Evolucion de la tasa de control entre 1981 y 1987. Med Clin (Barc) 1990; 94: 570-575.
58. Ministerio de Sanidad y Consumo. Indicadores de salud. Segunda evaluación en España del programa regional europeo de salud para todos. Madrid: Ministerio de Sanidad y Consumo, 1993.
59. Salleras LI, Pardell H, Salto E, Martín G, Serra L, Plans P. Consejo antitabaco. Med Clin (Barc) 1994; 101 (Supl 1): 109-117.
60. Carmena R. Dieta y colesterol sérico. Med Clin (Barc) 1989; 92: 56-59.
61. Banegas JR, Rodriguez-Artalejo F, Martin-Moreno JM, Rey Calero J. Corner menos grasa para prevenir la cardiopatia isquémica. Impacto potencial de las estralegias poblacional e individual de control de la colesterolemia en España. Med Clin (Barc) 1993; 101: 81-86.
62. Serra Majem L, Ribas L, Castalls C, Arija V, Lloveras G, Salleras L. Consejo nutricional y alimentario. Med Clin (Barc) 1994; 101 (Supl 1): 93-99.
63. Bellizzi MC, Franklin MF, Duthle CG, James WP, Vitamin E and coronary heart disnase: the European paradox. Eur J Clin Nutr 1994; 48: 822-831.
64. Moreiras O, Carbajal A, Perea I. Evolución de los hábitos alimentanos en España. Madrid: Ministerio de Sanidad y Consumo, 1990.
65. Evans AE, Rudavets JB, McCrum EE, Cambou JP, McClean R, Dousty-Blazy P et al. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJM 1995; 88: 469-477.
66. Urbano-Márquez A, Estruch R, Navarro-López F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1939; 301: 28-33.
67. Rubin E. Alcoholic myopathy in heart and skeletal muscle. N Engl J Med 1979; 320: 409-415.
68. Manolio TA, Levy D, Garrison RJ, Casteili WP, Kannel WB. Relation of alcohol intake to left ventricular mass: the Framingham study. J Am Coll Cardiol 1991; 17: 717-721.
69. Criqui MH. Alcohol and hypertension: new insights from population studies. Eur Heart J 1987; 8 (Supl B): 73-85.
70. Grupo de trabajo en hipertensión arterial y alcohol. Hipertensión arterial y alcohol. Madrid: Eurcolor, 1996.
71. Chari S, Teyssen S, Singer MV. Alcohol and gastric acid secretion in humans. Gut 1993; 34: 843-847.
72. Peterson WL, Barnet C, Walsh JH. Effect of intragastric infusions of ethanol and wine on serum gastrin concentration and gastric acid secretion. Gastroenterology 1986; 91: 1.390-1.395.
73. Singer MV, Eysselein VE, Goebell H. Beer and wine but not whisky and pure ethanol do stimulate release of gastrin in humans. Digestion 1983; 26: 73-79.
74. Singer MV, Leffmann C, Eysselein JE, Calden H, Goebell H. Action of ethanol and some alcoholic beverages on gastric acid secretion and release of gastrin in humans. Gastroenterology 1987; 93: 1.247-1.254.
75. Lenz HZ, Ferrari-Taylor J, Isenberg JI. Wine and five percent ethanol are potent stimulants of gastric acid secretion in humans. Gastroenterology 1983; 85: 1.082-1.087.
76. Hajnal F, Flores MC, Radley S, Valenzuela JE. Effect of alcohol and alcoholic beverages on meal-stimulated pancreatic secretion in humans Gastroenterology 1990; 98: 191-196.
77. Caballeria J. Efectos del alcohol sobre el tubo digestivo. En: Rodes J, Chantar C, editores. Actualidades en gastroenterologia y hepatologia-17. Barcelona: J Prous Editores, 1995; 155-164.
78. Grande L, Manterola C, Ros E, Lacima G, Pera M. Effects of red wine on 24-Hom esophageal pH and pressures in healthy volunteers. Dig Dis Sci 1997; 42: 1.189-1.194.
79. Pfeiffer A, Holgi B, Kaess H. Effect of ethanol and commonly ingested alcoholic beverages on gastric emptying and gastrointestinal transit. Clin Invest 1992; 70: 487-491.
80. Weisse ME, Eberly B, Person DA. Wine as a digestive aid: comparative antimicrobial effects of bismuth salicylate and red and white wine. Br Med J 1995; 311: 1.657-1,660.
81. Sheth NK, Wisnlewski TR, Franson TR. Survival of enteric pathogens in common beverages: an in vitro study. Am J Gastroenterol 1988; 83: 658-660.
82. Bellido Blasco JB, González Morán F, Arnedo Pena A, Galiano Ariandis JV, Safont Adsuara L, Herrero Carot C et al. Brote de infección alimentaria por Salmonella enteritidis. Posible efecto protector de las bebidas alcohólicas. Med Clin (Barc) 1996; 107: 641-644.
83. Cook KA, Mead PS, Mintz ED. Don't rely on drinking wine to prevent traveller's diarrhoea. Br Med J 1996; 312: 642.
84. Ingram LO, Buttke TM. Effects of alcohols on microorganisms. Adv Microb Physiol 1984; 25: 253-300.
85. Desenclos JCA, Klontz KC, Wilder MH, Gunn RA. The protective effect of alcohol on the occurrence of epidemic oyster-borne hepatitis A. Epidemiology 1992; 3: 371-374.
86. Viceconte G. Effect of ethanol on the sphinter of Oddi: an endoscopic manometric study. Gut 1983; 24: 20-27.
87. Gogel HK, Tandberg D, Strickland RG. Substances that interfere with gualac card tests: implications for gastric aspirate testing. Am J Emerg Med 1989; 7: 474-480.
88. Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem 1995; 235: 207-219.
89. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-220
90. Adami HO, Lund E, Bergstrom R, Meink O. Cigarette smoking, alcohol consumption, and risk of breast cancer in young women. Br J Cancer 1988; 58: 832-837.
91. Talamim R, La Vecchia C, Decarli A, Fraceschi S, Grattoni E, Grigoletto E et al. Social factors, diet and breast cancer in a Northern Italian population. Br J Cancer 1984; 49: 723-729.
92. La Vecchia C, Negri E, Parazzini F, Boyle P, Fasoli M, Gentile A et al. Alcohol and breast cancer: update from a Italian case-control study. Eur J Cancer Clin Oncol 1989; 25: 1.711-1.717.
93. Richardson S, De Vincenzi I, Pujol H, Gerber M. Alcohol consumption in a case-control study of breast cancer in southern France. Int J Cancer 1989; 44: 84-89.
94. Ferraroni M, Decarli A, Willett WC, Merabini E. Alcohol and breast cancer tisk: a case-control study from northern Italy. Int J Edpidemio 1991; 20: 859-864.
95. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 1988; 260: 652-656.
96. Martin-Moreno JM, Boyle P, Gorgojo L, Willett WC, González J, Villar F et al. Alcoholic beverage consumption and risk of breast cancer in Spain. Cancer Causes Control 1993; 4: 345-353.
97. Longnecker MP. Do hormones link alcohol with breast cancer? J Natl Cancer Inst 1993; 85: 692-693.
98. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994; 5: 73-82.
99. O'Connell DL, Huika BS, Chambless LE, Wildinson WE, Denbner DC, Cigarrette smoking, alcohol consumption, and breast cancer risk. J Natl Cancer Inst 1987; 78: 229-234.
100. Rohan TE, McMichael AJ. Alcohol consumption and risk of breast cancer. Int J Cancer 1988; 41: 695-699.
101. Harvey EB, Schairer C, Brinton LA, Hoover RN, Fraumeni JF Jr. Alcohol consumption and breast cancer. J Natl Cancer Inst 1987; 78: 657-661.
102. Toniolo P, Riboll E, Protta F, Charrel M, Cappa AP. Breast cancer and alcohol consumption: a case-control study in northern Italy. Cancer Res 1989; 49: 5.203-5.206.
103. Nasca PC, Baptiste MS, Field NA, Metzger BB, Black M, Kwon CS et al. An epidemiological case-control study of breast cancer and alcohol consumption. Int J Epidemiol 1990; 19: 532-538.
104. Ewertz M. Alcohol consumption and breast cancer risk in Denmark. Cancer Causes Control 1991; 2: 247-252.
105. Ginsburg ES, Wello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M et al. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA 1996; 276: 1.745-1.751.
106. Willed WC, Sacks F, Trichopoulou A, Drescher G, Fero-Luzzi A, Helsing E et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995; 61 (Supl): 1.402-1.406.
107. Hiatt RA. Alcohol consumption and breast cancer. Med Oncol Tumor Pharmacother 1990; 7: 143-151.
108. Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP et al. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst 1993; 85: 722-727.
109. Katsouyanni K, Boyle P, Trichopoulos D. Diet and urine estrogens among postmenopausal women. Oncology 1991; 48: 490-494.
110. London S, Willed W, Longcope C, McKinlay S. Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 1991; 53: 166-171.
111. Giovannuci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer. J Natl Cancer Inst 1995; 87: 265-273.
112. Kune GA, Vitetta L. Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer 1992; 18: 97-111.
113. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875-884.
114. Makos M, Nelkin BD, Lerman MI, Lafit F, Zbar B. Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 1992; 89: 1.929-1.933.
115. Swanson CA, Wilbanks GD, Twiggs LB, Mortel R. Berman ML, Barrett RJ et al. Moderate alcohol consumption and the risk of endometrial cancer. Epidemiology 1993; 4: 530-536.
116. Hoey J, Montvernay C, Lambert R Wine and tobacco: risk factors for gastric cancer in France. Am J Epidemiol 1981; 113: 668-674.
117. Falcao JM, Dias JA, Miranda AC, Deltao CN, Lacerda MM, Da Motta LC. Red wine consumption and gastric cancer in Portugal: a case-control study. Eur J Cancer Prev 1994; 3: 269-276.
118. Tavani A, Negri E, Franceschi S, Talamini R, La Vecchia C. Alcohol consumption and risk of prostate cancer. Nutr Cancer 1994; 21: 24-31.
119. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985; 834: 275-278.
120. Pace-Asclak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosamoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-219.
121. Hendriks HF, Veenstra J, Velthuis te Wierik EJ, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994; 308: 1.003-1.006.
122. Friedman GD, Klatsky AL. Is alcohol good for your health? N Engl J Med 1993; 329: 1.882-1.883.
123. Veenstra J, Velthuis te Wierik EJ, Kluft C. Alcohol and fibrinolysis. Fibrinolysis 1990; 2: 64-68.
124. Veenstra J, Kluft C, Ochulzen TH, VD Pol H, Wedel M, Schaafsma G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activators and plasminogen activator inhibitor. Thromb Haemost 1990; 63: 345-348.
125. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993, 341: 1.165-1.168.
126. Ridker PM, Hennekens CH, Stampfer MT, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-943.
127. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992; 117: 646-654.
128. Klatsky AL, Armstrong MA, Friedman GD. Alcohol use and subsequent cerebrovascular disease hospitalizations. Stroke 1989; 20: 741-746.
129. Kiechl S, Willett J, Egger G, Oberhollenzer M, Alchner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from Bruneck study. Stroke 1994; 25: 1.593-1.598.
130. Jarisch R, Wantke F. Wine and headache. Int Arch Allergy Immunol 1996; 110: 7-12.
131. Sandler M, Li NY, Jarrett N, Glover V. Dietary migraine: recent progress in the red (and white) wine story. Cephalalgia 1995; 15: 101-103.
132. Littlewood JT, Gibb C, Glover V, Dandler M, Davies PT, Rose FC. Red wine as a cause of migraine. Lancet 1988; 1: 558-559.
133. Slerakowski R, Finlayson B, Landes RR, Finlayson CD, Slerakowski N. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 1978; 15: 438-441.
134. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-years study in Rochester, Minnesota. Kidney Int 1979; 16: 624-631.
135. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol 1984; 56: 122-124.
136. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833-838.
137. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996; 143: 240-247.
138. Robertson GL. Regulation of vasopressin secretion. En: Seldin DW, Giebisch G, editores The kidney: physiology and pathophysiology (2. ed.). Nueva York: Raven Press, 1992.
139. Chester AC. Red Wine fatigue. Arch Intern Med 1994; 154: 1.163.
140. Jarman J, Glover V, Dandler M. Release of (C14) 5-hydroxytryptamine from platelets by red wine. Life Sci 1991; 48: 2.297-3.000.
141. Poikolainen K. Alcohol and mortality: a review. J Clin Epidemiol 1995; 48: 455-465.
142. Ellison RC. Does moderate alcohol consumption prolong life? Nueva York: American Council on Science and Health, 1993; 1-23.
143. Kono S, Ideda M, Tokudome S, Nishizumi M, Kuratsune M. Alcohol and mortality: a cohort study of male Japanese physicians. Int J Epidemiol 1986; 15: 527-532.
144. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988; 2: 1.267-1.273.
145. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990; 1: 342-348.
146. Coate D. Moderate drinking and coronary heart disease mortality evidence from NHANES I and the NHANES I follow-up. Am J Public Health 1993; 83: 888-890.
147. Gronbaek M, Dels A, Sorensen TI, Becker V, Schnohr P, Jensen G et al. Mortality associated with moderate intakes of wine, beer or spirits. Br Med J 1995; 310: 1.165-1.169.
148. Gronbaek MN, Dels A, Sorensen TI, Becker PU, Schnohr P, Jensen GB. Mortality differences associated with moderate consumption of beer, wine and spirits. Ugesdr Laeger 1996; 158: 2.258-2.261.
149. Berberian KM, Van Duijn CM, Hons AW, Valkenburg HA, Hofman A. Alcohol and mortality. Results from the EPOZ (Epidemiologic Study of Cardiovascular Risk Indicators) follow-up study. Eur J Epidemiol 1994; 10: 587-593.
150. Marmot MG, Shipley MJ, Rose G, Thomas BJ. Alcohol and mortality: a U-shaped curve. Lancet 1981; 14: 580-583.
151. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994; 344: 1.719-1.723.
152. Artaud-Wild SM, Connor S, Sexton G, Connor W. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation 1993; 88: 2.771-2.779.